CD33 and Alzheimer disease: Overall, this study is a major step forward towards elucidating the in vivo roles of human-specific CD33 protein isoforms in microglia, further deciphering the functional aspects of this GWAS-identified risk factor, and helping to define early events that contribute to AD pathogenesis.